A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study.

A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study. Blood. 2008 Sep 15; 112(6):2242-7.

View in: PubMed

subject areas

Acute Disease
Adult
Aged
Aged, 80 and over
Antithrombin III
Dose-Response Relationship, Drug
Double-Blind Method
Drug-Related Side Effects and Adverse Reactions
Female
Hemorrhage
Humans
Male
Middle Aged
Morpholines
Rivaroxaban
Thiophenes
Treatment Outcome
Ultrasonography
Venous Thrombosis

authors with profiles

Gary E Raskob